Recently, numerous useful prognostic biomarkers in different types of cancer, including CRC, have been reported by combining these individual markers, such as the lymphocyte‐to‐CRP ratio,7 CRP‐to‐albumin ratio,13 neutrophil‐to‐lymphocyte ratio,14 and platelet‐to‐lymphocyte ratio.15 The gene discussed is CRP; the disease is colorectal carcinoma.